골다공증 치료 및 골절 치료 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 약물 유형별, 투여 경로별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type, By Route of Administration, By Distribution Channel, By Region & Competition, 2020-2030F
상품코드:1691816
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 골다공증 치료 및 골절 치료 시장은 2024년 151억 5,000만 달러로 평가되며, 2030년까지 4.43%의 CAGR로 예측 기간 동안 196억 5,000만 달러에 달할 것으로 예상됩니다.
골다공증은 뼈의 약화를 특징으로 하는 광범위한 골격계 질환으로, 골절의 위험을 증가시키고 골절 치유 합병증을 유발합니다. 이 질환은 특히 세계 인구의 고령화가 진행됨에 따라 세계 보건에 큰 도전이 되고 있습니다. 세계 골다공증 치료 및 골절 치료 시장은 헬스케어 전문가, 제약회사, 의학 연구자들이 이 쇠약해진 상태에 맞서기 위해 노력하면서 괄목할 만한 성장과 혁신을 목격하고 있습니다. 골다공증은 골절이 발생할 때까지 자각증상 없이 진행되기 때문에 종종 '침묵의 병'이라고 불립니다. 골다공증이 생기면 뼈는 밀도와 강도를 잃고 다공성이 되어 부서지기 쉽습니다. 그 결과, 특히 고관절, 척추, 손목에서 골절이 발생하기 쉽습니다. 골다공증은 주로 폐경기 이후 여성에게 많이 발생하지만, 남성이나 모든 연령대의 사람들에게도 영향을 미칠 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
151억 5,000만 달러
시장 규모 : 2030년
196억 5,000만 달러
CAGR : 2025-2030년
4.43%
급성장 부문
칼시토닌
최대 시장
북미
이 시장에서는 약물 치료, 의료기기, 수술, 생활습관 개선 등 다양한 치료 옵션이 제공되고 있습니다. 이러한 옵션들은 골다공증 치료뿐만 아니라 골절 후 치유 과정을 향상시키는 것을 목표로 하고 있습니다. 최소침습 수술 기술이나 재생치료와 같은 첨단 기술은 골다공증 치료와 골절 치료의 효과를 높이고 있습니다.
주요 시장 촉진요인
고령화 인구 증가로 세계 골다공증 치료 및 골절 치료 시장 성장 견인
주요 시장 과제
인구 고령화
주요 시장 동향
기술 발전
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 세계의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
약물 유형별(칼시토닌, 비스포스포네이트, 호르몬 대체요법, 아나볼릭, 기타)
투여 경로별(경구, 주사)
유통 채널별(병원 약국, 소매 약국, E-Commerce)
지역별
기업별(2024)
시장 맵
약 종류별
투여 경로별
유통 채널별
지역별
제5장 아시아태평양의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
약 종류별
투여 경로별
유통 채널별
국가별
아시아태평양 : 국가별 분석
중국
인도
호주
일본
한국
제6장 유럽의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
스페인
이탈리아
영국
제7장 북미의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
멕시코
캐나다
제8장 남미의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제9장 중동 및 아프리카의 골다공증 치료 및 골절 치료 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제10장 시장 역학
성장 촉진요인
과제
제11장 시장 동향과 발전
최근 동향
제품 출시
인수합병
제12장 세계의 골다공증 치료 및 골절 치료 시장 : SWOT 분석
제13장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제14장 경쟁 구도
GlaxoSmithKline plc
Medtronic Plc.
Merck & Co. Inc.
Novartis AG
Pfizer inc.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd
Stryker Corporation
Teva Pharmaceutical Industries Ltd.
Orthofix US LLC
제15장 전략적 제안
제16장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
Global Anti Osteoporosis Therapy and Fracture Healing Market was valued at USD 15.15 Billion in 2024 and is and is expected to reach USD 19.65 Billion in the forecast period with a CAGR of 4.43% through 2030. Osteoporosis is a pervasive skeletal disorder characterized by weakened bones, increasing the risk of fractures and, subsequently, fracture healing complications. This condition poses a significant global health challenge, especially as the world's population continues to age. The global anti-osteoporosis therapy and fracture healing market has been witnessing remarkable growth and innovation as healthcare professionals, pharmaceutical companies, and medical researchers seek to combat this debilitating condition. Osteoporosis is often referred to as the 'silent disease' because it progresses without symptoms until a fracture occurs. In osteoporotic individuals, bones lose their density and strength, becoming more porous and fragile. This results in a higher susceptibility to fractures, particularly in the hip, spine, and wrist. Osteoporosis predominantly affects postmenopausal women, but it can also impact men and individuals of all ages.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 15.15 Billion
Market Size 2030
USD 19.65 Billion
CAGR 2025-2030
4.43%
Fastest Growing Segment
Calcitonin
Largest Market
North America
The market offers a diverse range of treatment options, including medications, medical devices, surgical procedures, and lifestyle modifications. These options aim to not only treat osteoporosis but also enhance the healing process after a fracture. Cutting-edge technologies, such as minimally invasive surgical techniques and regenerative therapies, are enhancing the effectiveness of osteoporosis treatment and fracture healing.
Key Market Drivers
Rising Aging Population is Driving the Global Anti Osteoporosis Therapy and Fracture Healing Market
The global healthcare landscape is undergoing a significant transformation, largely driven by the aging population. As people live longer, they are more likely to experience age-related health issues, one of the most common being osteoporosis. This bone disease, characterized by decreased bone density and increased fragility, poses a considerable threat to the elderly, resulting in fractures that can have debilitating consequences. The rising aging demographic has given rise to a thriving market for anti-osteoporosis therapy and fracture healing solutions.
The world's population is aging at an unprecedented rate. Advancements in healthcare, nutrition, and lifestyle choices have led to increased life expectancy. This demographic shift is observed across developed and developing countries alike, albeit at varying rates. According to the United Nations, by 2050, the global population aged 60 and above will surpass 2 billion, accounting for more than 20% of the total population. As individuals age, their bone density naturally decreases. This gradual weakening of the bones is a significant factor behind the increased prevalence of osteoporosis. Osteoporosis is often referred to as a "silent disease" because it progresses without obvious symptoms until a fracture occurs. Fractures, especially hip fractures, can have devastating consequences for the elderly, leading to reduced mobility, chronic pain, and increased mortality rates.
Growing awareness about osteoporosis and its implications on bone health has encouraged individuals to seek early diagnosis and treatment. This has driven the demand for anti-osteoporosis therapies. The development of innovative diagnostic tools and therapeutic options for osteoporosis has improved the treatment landscape. This includes medications to strengthen bones and reduce fracture risk, as well as cutting-edge surgical techniques for fracture healing. Public and private research organizations, along with pharmaceutical companies, are investing heavily in osteoporosis research. This collaboration has led to a better understanding of the disease and the development of more effective treatments.
Key Market Challenges
Aging Population
One of the most significant challenges facing the market is the global aging population. As people live longer, the prevalence of osteoporosis and fractures increases. The demand for effective therapies and fracture healing solutions is surging, leading to a strain on healthcare systems and resources. This challenge necessitates the development of cost-effective and scalable treatments to meet the growing demand.
Key Market Trends
Technological Advancements
Technological advancements have revolutionized the diagnosis of osteoporosis. Traditional methods, such as X-rays, while still valuable, have limitations. Dual-energy X-ray absorptiometry (DXA) scans are now widely used for bone density measurements, enabling early detection of osteoporosis. Furthermore, portable and cost-effective devices that use ultrasound to measure bone density are becoming increasingly accessible, allowing for early screening in primary care settings. Imaging technologies like magnetic resonance imaging (MRI) and computed tomography (CT) scans have evolved to provide better visualization of bone structure, helping doctors detect fractures and monitor healing. Three-dimensional printing and modeling have also made significant strides, allowing for the creation of personalized implants and prosthetics for patients with complex fractures. Pharmaceutical companies are investing in innovative drug development to combat osteoporosis. Targeted therapies, such as monoclonal antibodies and selective estrogen receptor modulators, are becoming available, offering a more specific and effective approach to treatment. Additionally, genetic testing and personalized medicine are contributing to the development of tailored treatment plans based on individual patients' genetics, lifestyle, and risk factors.
Telemedicine and digital health solutions are playing a crucial role in osteoporosis management. Patients can now access consultations with specialists remotely, ensuring timely and efficient care. Wearable devices and mobile apps provide tools for monitoring bone health, encouraging adherence to therapy regimens, and enabling real-time data transmission to healthcare providers for a more comprehensive approach to care. In the field of fracture healing, surgical techniques have advanced significantly. Minimally invasive procedures, such as arthroscopy, have reduced recovery times and complications associated with surgery. In orthopedics, advancements in implant materials and design have improved the success rates of joint replacements, enhancing the quality of life for patients.
The development of regenerative medicine approaches for fracture healing is a promising avenue. Stem cell therapies, tissue engineering, and growth factors are being explored to accelerate the body's natural healing processes. These techniques aim to not only repair the bone but also restore its functionality, reducing the risk of long-term complications. Artificial intelligence (AI) and data analytics are enhancing disease prediction, diagnosis, and treatment outcomes in osteoporosis. Machine learning algorithms can analyze large datasets to identify high-risk individuals and predict fractures, enabling early intervention. AI is also used to optimize drug discovery processes, potentially leading to more effective treatments.
Key Market Players
GlaxoSmithKline plc
Medtronic Plc.
Merck & Co. Inc.
Novartis AG
Pfizer inc.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd
Stryker Corporation
Teva Pharmaceutical Industries Ltd.
Orthofix US LLC
Report Scope:
In this report, the Global Anti Osteoporosis Therapy and Fracture Healing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Anti Osteoporosis Therapy and Fracture Healing Market, By Drug Type:
Calcitonin
Bisphosphonates
Hormone Replacement Therapy
Anabolic
Others
Anti Osteoporosis Therapy and Fracture Healing Market, By Route of Administration:
Oral
Injectable
Anti Osteoporosis Therapy and Fracture Healing Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Anti Osteoporosis Therapy and Fracture Healing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Anti Osteoporosis Therapy and Fracture Healing Market.
Available Customizations:
Global Anti Osteoporosis Therapy and Fracture Healing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Global Anti Osteoporosis Therapy and Fracture Healing Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Drug Type (Calcitonin, Bisphosphonates, Hormone Replacement Therapy, Anabolic, Others)
4.2.2. By Route of Administration (Oral, Injectable)
4.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce)
4.2.4. By Region
4.2.5. By Company (2024)
4.3. Market Map
4.3.1. By Drug Type
4.3.2. By Route of Administration
4.3.3. By Distribution Channel
4.3.4. By Region
5. Asia Pacific Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type
5.2.2. By Route of Administration
5.2.3. By Distribution Channel
5.2.4. By Country
5.3. Asia Pacific: Country Analysis
5.3.1. China Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.3.1.1. Market Size & Forecast
5.3.1.1.1. By Value
5.3.1.2. Market Share & Forecast
5.3.1.2.1. By Drug Type
5.3.1.2.2. By Route of Administration
5.3.1.2.3. By Distribution Channel
5.3.2. India Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.3.2.1. Market Size & Forecast
5.3.2.1.1. By Value
5.3.2.2. Market Share & Forecast
5.3.2.2.1. By Drug Type
5.3.2.2.2. By Route of Administration
5.3.2.2.3. By Distribution Channel
5.3.3. Australia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.3.3.1. Market Size & Forecast
5.3.3.1.1. By Value
5.3.3.2. Market Share & Forecast
5.3.3.2.1. By Drug Type
5.3.3.2.2. By Route of Administration
5.3.3.2.3. By Distribution Channel
5.3.4. Japan Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.3.4.1. Market Size & Forecast
5.3.4.1.1. By Value
5.3.4.2. Market Share & Forecast
5.3.4.2.1. By Drug Type
5.3.4.2.2. By Route of Administration
5.3.4.2.3. By Distribution Channel
5.3.5. South Korea Anti Osteoporosis Therapy and Fracture Healing Market Outlook
5.3.5.1. Market Size & Forecast
5.3.5.1.1. By Value
5.3.5.2. Market Share & Forecast
5.3.5.2.1. By Drug Type
5.3.5.2.2. By Route of Administration
5.3.5.2.3. By Distribution Channel
6. Europe Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Route of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. Europe: Country Analysis
6.3.1. France Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Germany Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Spain Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By Distribution Channel
6.3.4. Italy Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Drug Type
6.3.4.2.2. By Route of Administration
6.3.4.2.3. By Distribution Channel
6.3.5. United Kingdom Anti Osteoporosis Therapy and Fracture Healing Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Drug Type
6.3.5.2.2. By Route of Administration
6.3.5.2.3. By Distribution Channel
7. North America Anti Osteoporosis Therapy and Fracture Healing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Route of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Anti Osteoporosis Therapy and Fracture Healing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. Mexico Anti Osteoporosis Therapy and Fracture Healing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. Canada Anti Osteoporosis Therapy and Fracture Healing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Distribution Channel
8. South America Anti Osteoporosis Therapy and Fracture Healing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Route of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. South America: Country Analysis
8.3.1. Brazil Anti Osteoporosis Therapy and Fracture Healing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. Argentina Anti Osteoporosis Therapy and Fracture Healing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. Colombia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Distribution Channel
9. Middle East and Africa Anti Osteoporosis Therapy and Fracture Healing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Route of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. MEA: Country Analysis
9.3.1. South Africa Anti Osteoporosis Therapy and Fracture Healing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Saudi Arabia Anti Osteoporosis Therapy and Fracture Healing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. UAE Anti Osteoporosis Therapy and Fracture Healing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. Global Anti Osteoporosis Therapy and Fracture Healing Market: SWOT Analysis
